Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liftactiv B3 for Facial Post-acne PIHP
NCT05327361Phase 2Terminated
- Sponsor
- University of Miami
- Start
- Mar 2022
- Primary completion
- Jan 2023
- Countries
- 1
01
Overview
Phase 2 trial in Post-inflammatory hyperpigmentation (PIH) (2 arms), sponsored by University of Miami. Primary endpoint: Post Inflammatory Hyperpigmentation Change at 3 months. Started Mar 2022; status: terminated.
02
Conditions
Post-inflammatory hyperpigmentation (PIH)
Beyond the preview
Go deeper on NCT05327361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05327361.